Logo image of MYO

MYOMO INC (MYO) Stock Fundamental Analysis

NYSEARCA:MYO - NYSE Arca - US62857J2015 - Common Stock - Currency: USD

3.22  -0.14 (-4.17%)

After market: 3.2005 -0.02 (-0.61%)

Fundamental Rating

4

MYO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. While MYO seems to be doing ok healthwise, there are quite some concerns on its profitability. MYO is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MYO has reported negative net income.
In the past year MYO has reported a negative cash flow from operations.
MYO had negative earnings in each of the past 5 years.
MYO had a negative operating cash flow in each of the past 5 years.
MYO Yearly Net Income VS EBIT VS OCF VS FCFMYO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -14.64%, MYO perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
The Return On Equity of MYO (-25.02%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -14.64%
ROE -25.02%
ROIC N/A
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
MYO Yearly ROA, ROE, ROICMYO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

MYO has a better Gross Margin (71.23%) than 81.48% of its industry peers.
MYO's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for MYO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
MYO Yearly Profit, Operating, Gross MarginsMYO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

6

2. Health

2.1 Basic Checks

MYO does not have a ROIC to compare to the WACC, probably because it is not profitable.
MYO has more shares outstanding than it did 1 year ago.
MYO has more shares outstanding than it did 5 years ago.
There is no outstanding debt for MYO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MYO Yearly Shares OutstandingMYO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MYO Yearly Total Debt VS Total AssetsMYO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 1.48, we must say that MYO is in the distress zone and has some risk of bankruptcy.
MYO has a Altman-Z score of 1.48. This is comparable to the rest of the industry: MYO outperforms 57.67% of its industry peers.
MYO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.48
ROIC/WACCN/A
WACC9.12%
MYO Yearly LT Debt VS Equity VS FCFMYO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

MYO has a Current Ratio of 3.22. This indicates that MYO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MYO (3.22) is comparable to the rest of the industry.
A Quick Ratio of 2.91 indicates that MYO has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.91, MYO is doing good in the industry, outperforming 62.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 2.91
MYO Yearly Current Assets VS Current LiabilitesMYO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.44% over the past year.
The Revenue has grown by 69.17% in the past year. This is a very strong growth!
MYO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.36% yearly.
EPS 1Y (TTM)44.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)69.17%
Revenue growth 3Y32.93%
Revenue growth 5Y53.36%
Sales Q2Q%161.83%

3.2 Future

MYO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.96% yearly.
MYO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.48% yearly.
EPS Next Y31.08%
EPS Next 2Y47.08%
EPS Next 3Y47.18%
EPS Next 5Y40.96%
Revenue Next Year65.21%
Revenue Next 2Y44.95%
Revenue Next 3Y36.58%
Revenue Next 5Y28.48%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MYO Yearly Revenue VS EstimatesMYO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
MYO Yearly EPS VS EstimatesMYO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MYO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 115.93, MYO can be considered very expensive at the moment.
MYO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MYO is cheaper than 64.55% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.94, MYO is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 115.93
MYO Price Earnings VS Forward Price EarningsMYO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYO Per share dataMYO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MYO does not grow enough to justify the current Price/Earnings ratio.
MYO's earnings are expected to grow with 47.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.08%
EPS Next 3Y47.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYOMO INC

NYSEARCA:MYO (5/21/2025, 8:19:50 PM)

After market: 3.2005 -0.02 (-0.61%)

3.22

-0.14 (-4.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners54.37%
Inst Owner Change7.69%
Ins Owners5.86%
Ins Owner Change0.35%
Market Cap115.86M
Analysts80
Price Target9.44 (193.17%)
Short Float %2.96%
Short Ratio1.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.61%
Min EPS beat(2)28.72%
Max EPS beat(2)50.5%
EPS beat(4)3
Avg EPS beat(4)33.14%
Min EPS beat(4)-4.22%
Max EPS beat(4)57.57%
EPS beat(8)5
Avg EPS beat(8)17.94%
EPS beat(12)9
Avg EPS beat(12)17.61%
EPS beat(16)12
Avg EPS beat(16)16.64%
Revenue beat(2)2
Avg Revenue beat(2)16.57%
Min Revenue beat(2)12.41%
Max Revenue beat(2)20.73%
Revenue beat(4)3
Avg Revenue beat(4)6.69%
Min Revenue beat(4)-8.67%
Max Revenue beat(4)20.73%
Revenue beat(8)6
Avg Revenue beat(8)6.55%
Revenue beat(12)8
Avg Revenue beat(12)7.61%
Revenue beat(16)12
Avg Revenue beat(16)15.01%
PT rev (1m)0%
PT rev (3m)20.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.92%
EPS NY rev (1m)0%
EPS NY rev (3m)-81.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)16.37%
Revenue NY rev (1m)17.51%
Revenue NY rev (3m)17.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 115.93
P/S 3.56
P/FCF N/A
P/OCF N/A
P/B 4.69
P/tB 4.69
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)0.03
Fwd EY0.86%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.9
BVpS0.69
TBVpS0.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.64%
ROE -25.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.23%
FCFM N/A
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
F-Score5
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 175.05%
Cap/Sales 4.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.22
Quick Ratio 2.91
Altman-Z 1.48
F-Score5
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)74.6%
Cap/Depr(5y)98.18%
Cap/Sales(3y)1.88%
Cap/Sales(5y)1.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y31.08%
EPS Next 2Y47.08%
EPS Next 3Y47.18%
EPS Next 5Y40.96%
Revenue 1Y (TTM)69.17%
Revenue growth 3Y32.93%
Revenue growth 5Y53.36%
Sales Q2Q%161.83%
Revenue Next Year65.21%
Revenue Next 2Y44.95%
Revenue Next 3Y36.58%
Revenue Next 5Y28.48%
EBIT growth 1Y24.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year82.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.7%
OCF growth 3YN/A
OCF growth 5YN/A